Immunotherapy hope for men with super-deadly prostate cancer

Immunotherapy drugs may offer a lifeline to men with the deadliest forms of prostate cancer, research has suggested.

Immunotherapy hope for men with super-deadly prostate cancer

Immunotherapy drugs may offer a lifeline to men with the deadliest forms of prostate cancer, research has suggested.

Scientists have identified a sub-group of men with super-aggressive prostate cancer caused by DNA repair defects.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited